105 related articles for article (PubMed ID: 15102695)
1. Identification and characterization of a T-helper peptide from carcinoembryonic antigen.
Ruiz M; Kobayashi H; Lasarte JJ; Prieto J; Borrás-Cuesta F; Celis E; Sarobe P
Clin Cancer Res; 2004 Apr; 10(8):2860-7. PubMed ID: 15102695
[TBL] [Abstract][Full Text] [Related]
2. Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.
Kobayashi H; Omiya R; Ruiz M; Huarte E; Sarobe P; Lasarte JJ; Herraiz M; Sangro B; Prieto J; Borras-Cuesta F; Celis E
Clin Cancer Res; 2002 Oct; 8(10):3219-25. PubMed ID: 12374692
[TBL] [Abstract][Full Text] [Related]
3. Identification of a MHC class-II restricted epitope in carcinoembryonic antigen.
Shen L; Schroers R; Hammer J; Huang XF; Chen SY
Cancer Immunol Immunother; 2004 May; 53(5):391-403. PubMed ID: 14624313
[TBL] [Abstract][Full Text] [Related]
4. Identification of HLA-B27-restricted cytotoxic T lymphocyte epitope from carcinoembryonic antigen.
Huarte E; Sarobe P; Lasarte JJ; Brem G; Weiss EH; Prieto J; Borrás-Cuesta F
Int J Cancer; 2002 Jan; 97(1):58-63. PubMed ID: 11774244
[TBL] [Abstract][Full Text] [Related]
5. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
6. Functional HLA-DR T cell epitopes of CEA identified in patients with colorectal carcinoma immunized with the recombinant protein CEA.
Ullenhag GJ; Fagerberg J; Strigård K; Frödin JE; Mellstedt H
Cancer Immunol Immunother; 2004 Apr; 53(4):331-7. PubMed ID: 14605762
[TBL] [Abstract][Full Text] [Related]
7. Induction of carbohydrate-specific antibodies in HLA-DR transgenic mice by a synthetic glycopeptide: a potential anti cancer vaccine for human use.
Vichier-Guerre S; Lo-Man R; BenMohamed L; Dériaud E; Kovats S; Leclerc C; Bay S
J Pept Res; 2003 Sep; 62(3):117-24. PubMed ID: 12895273
[TBL] [Abstract][Full Text] [Related]
8. Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides.
Liu KJ; Wang CC; Chen LT; Cheng AL; Lin DT; Wu YC; Yu WL; Hung YM; Yang HY; Juang SH; Whang-Peng J
Clin Cancer Res; 2004 Apr; 10(8):2645-51. PubMed ID: 15102666
[TBL] [Abstract][Full Text] [Related]
9. Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen.
Kobayashi H; Lu J; Celis E
Cancer Res; 2001 Oct; 61(20):7577-84. PubMed ID: 11606397
[TBL] [Abstract][Full Text] [Related]
10. Human telomerase reverse transcriptase-specific T-helper responses induced by promiscuous major histocompatibility complex class II-restricted epitopes.
Schroers R; Shen L; Rollins L; Rooney CM; Slawin K; Sonderstrup G; Huang XF; Chen SY
Clin Cancer Res; 2003 Oct; 9(13):4743-55. PubMed ID: 14581345
[TBL] [Abstract][Full Text] [Related]
11. Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells.
Kawashima I; Tsai V; Southwood S; Takesako K; Sette A; Celis E
Cancer Res; 1999 Jan; 59(2):431-5. PubMed ID: 9927058
[TBL] [Abstract][Full Text] [Related]
12. Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.
Karyampudi L; Krco CJ; Kalli KR; Erskine CL; Hartmann LC; Goodman K; Ingle JN; Maurer MJ; Nassar A; Yu C; Disis ML; Wettstein PJ; Fikes JD; Beebe M; Ishioka G; Knutson KL
Cancer Immunol Immunother; 2010 Jan; 59(1):161-71. PubMed ID: 19621224
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential HLA-A *0201 restricted CTL epitopes derived from the epithelial cell adhesion molecule (Ep-CAM) and the carcinoembryonic antigen (CEA).
Ras E; van der Burg SH; Zegveld ST; Brandt RM; Kuppen PJ; Offringa R; Warnarr SO; van de Velde CJ; Melief CJ
Hum Immunol; 1997 Mar; 53(1):81-9. PubMed ID: 9127151
[TBL] [Abstract][Full Text] [Related]
14. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine.
Tsang KY; Zaremba S; Nieroda CA; Zhu MZ; Hamilton JM; Schlom J
J Natl Cancer Inst; 1995 Jul; 87(13):982-90. PubMed ID: 7629885
[TBL] [Abstract][Full Text] [Related]
15. Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factor.
Ullenhag GJ; Frödin JE; Jeddi-Tehrani M; Lidströmer N; Strigård K; Eriksson E; Samanci A; Choudhury A; Nilsson B; Rossmann ED; Mosolits S; Mellstedt H
Clin Cancer Res; 2004 May; 10(10):3273-81. PubMed ID: 15161680
[TBL] [Abstract][Full Text] [Related]
16. Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.
Huarte E; Sarobe P; Lu J; Casares N; Lasarte JJ; Dotor J; Ruiz M; Prieto J; Celis E; Borrás-Cuesta F
Clin Cancer Res; 2002 Jul; 8(7):2336-44. PubMed ID: 12114438
[TBL] [Abstract][Full Text] [Related]
17. Engineered promiscuous T helper peptides for the induction of immune responses.
Ruiz M; Llopiz D; Zabaleta A; Lasarte JJ; Borrás-Cuesta F; Sarobe P
Mol Immunol; 2007 Mar; 44(9):2205-12. PubMed ID: 17157914
[TBL] [Abstract][Full Text] [Related]
18. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
Zaremba S; Barzaga E; Zhu M; Soares N; Tsang KY; Schlom J
Cancer Res; 1997 Oct; 57(20):4570-7. PubMed ID: 9377571
[TBL] [Abstract][Full Text] [Related]
19. HLA-A*0201-restricted CEA-derived peptide CAP1 is not a suitable target for T-cell-based immunotherapy.
Fauquembergue E; Toutirais O; Tougeron D; Drouet A; Le Gallo M; Desille M; Cabillic F; de La Pintière CT; Iero M; Rivoltini L; Baert-Desurmont S; Leprince J; Vaudry H; Sesboué R; Frébourg T; Latouche JB; Catros V
J Immunother; 2010 May; 33(4):402-13. PubMed ID: 20386466
[TBL] [Abstract][Full Text] [Related]
20. Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells.
Parkhurst MR; Joo J; Riley JP; Yu Z; Li Y; Robbins PF; Rosenberg SA
Clin Cancer Res; 2009 Jan; 15(1):169-80. PubMed ID: 19118044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
